YU39480B - Process for obtaining 4,5,6,7-tetrahydrotheno(2,3-c)pyridine derivatives - Google Patents

Process for obtaining 4,5,6,7-tetrahydrotheno(2,3-c)pyridine derivatives

Info

Publication number
YU39480B
YU39480B YU1462/76A YU146276A YU39480B YU 39480 B YU39480 B YU 39480B YU 1462/76 A YU1462/76 A YU 1462/76A YU 146276 A YU146276 A YU 146276A YU 39480 B YU39480 B YU 39480B
Authority
YU
Yugoslavia
Prior art keywords
tetrahydrotheno
obtaining
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
YU1462/76A
Other languages
English (en)
Other versions
YU146276A (en
Inventor
J P Mafrand
Original Assignee
Parcor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor filed Critical Parcor
Publication of YU146276A publication Critical patent/YU146276A/xx
Publication of YU39480B publication Critical patent/YU39480B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
YU1462/76A 1975-06-27 1976-06-15 Process for obtaining 4,5,6,7-tetrahydrotheno(2,3-c)pyridine derivatives YU39480B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7520241A FR2315274A1 (fr) 1975-06-27 1975-06-27 Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications

Publications (2)

Publication Number Publication Date
YU146276A YU146276A (en) 1982-05-31
YU39480B true YU39480B (en) 1984-12-31

Family

ID=9157178

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1462/76A YU39480B (en) 1975-06-27 1976-06-15 Process for obtaining 4,5,6,7-tetrahydrotheno(2,3-c)pyridine derivatives

Country Status (26)

Country Link
US (1) US4075340A (el)
JP (1) JPS607633B2 (el)
AR (1) AR211777A1 (el)
AT (1) AT347950B (el)
BE (1) BE843402A (el)
CA (1) CA1071635A (el)
CH (1) CH596169A5 (el)
DD (1) DD125080A5 (el)
DE (1) DE2628045A1 (el)
DK (1) DK279976A (el)
ES (1) ES449191A1 (el)
FR (1) FR2315274A1 (el)
GB (1) GB1492239A (el)
GR (1) GR60042B (el)
HU (1) HU172697B (el)
IE (1) IE43915B1 (el)
IL (1) IL49702A (el)
LU (1) LU75230A1 (el)
MX (1) MX3565E (el)
NL (1) NL183032C (el)
PL (1) PL105962B1 (el)
PT (1) PT65271B (el)
SE (1) SE421698B (el)
SU (1) SU628820A3 (el)
YU (1) YU39480B (el)
ZA (1) ZA763270B (el)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127580A (en) * 1975-02-07 1978-11-28 Parcor Process for the preparation of thieno-pyridine derivatives
FR2395271A1 (fr) * 1977-06-21 1979-01-19 Parcor Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines
US4749692A (en) * 1977-06-22 1988-06-07 Sanofi, S.A. Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
FR2397417A1 (fr) * 1977-07-12 1979-02-09 Parcor Procede de preparation de derives de la thienopyridine
AT368504B (de) * 1977-10-15 1982-10-25 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine
US4321266A (en) * 1980-10-06 1982-03-23 Sanofi 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine
FR2508453A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de derives des (thienyl-2)- et thienyl-3)-2 ethylamines et produits ainsi obtenus
US4547514A (en) * 1983-12-05 1985-10-15 A. H. Robins Company, Incorporated Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity
DE3736664A1 (de) * 1987-10-29 1989-05-11 Boehringer Ingelheim Kg Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
AU4698299A (en) 1998-06-30 2000-01-17 Du Pont Pharmaceuticals Company 5-HT7 receptor antagonists
WO2000014090A1 (en) * 1998-09-02 2000-03-16 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[2,3-c]pyridine derivatives
US6090797A (en) * 1998-09-02 2000-07-18 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
JP2005522457A (ja) * 2002-02-26 2005-07-28 ノース ショア−ロング アイランド ジューイッシュ リサーチ インスティチュート 脳ムスカリン性レセプターの刺激による炎症性サイトカイン産生の阻害
JP2007530586A (ja) 2004-03-25 2007-11-01 ザ ファインスタイン インスティテュート フォー メディカル リサーチ 神経性止血法
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CA2593079C (en) 2004-12-27 2014-08-19 North Shore-Long Island Jewish Research Institute Treating inflammatory disorders by electrical vagus nerve stimulation
WO2009029614A1 (en) 2007-08-27 2009-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
CN102215909B (zh) 2008-11-18 2014-09-10 赛博恩特医疗器械公司 优化用于消炎刺激的电极放置的装置和方法
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
WO2010144578A2 (en) 2009-06-09 2010-12-16 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
EP3636314B1 (en) 2009-12-23 2021-09-08 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
CN103619405B (zh) 2011-05-09 2015-11-25 赛博恩特医疗器械公司 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活
CN104364257B (zh) 2012-03-23 2017-03-01 纪念斯隆-凯特琳癌症中心 5‑酰基‑6,7‑二氢噻吩并[3,2‑c]吡啶类化合物对胰腺及相关癌症的治疗作用
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US10011585B2 (en) 2014-07-28 2018-07-03 Merck Sharp & Dohme Corp. Factor XIa inhibitors
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
WO2017127756A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Control of vagal stimulation
US10314501B2 (en) 2016-01-20 2019-06-11 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
JP2023526080A (ja) 2020-05-21 2023-06-20 ザ・フェインステイン・インスティチュート・フォー・メディカル・リサーチ 迷走神経刺激のためのシステムおよび方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (el) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
DK279976A (da) 1976-12-28
US4075340A (en) 1978-02-21
ATA461776A (de) 1978-06-15
GB1492239A (en) 1977-11-16
IE43915L (en) 1976-12-27
NL183032B (nl) 1988-02-01
PT65271A (fr) 1976-07-01
FR2315274B1 (el) 1979-08-10
PT65271B (fr) 1977-12-10
ES449191A1 (es) 1977-12-01
CA1071635A (en) 1980-02-12
PL105962B1 (pl) 1979-11-30
AR211777A1 (es) 1978-03-15
NL7606574A (nl) 1976-12-29
HU172697B (hu) 1978-11-28
DD125080A5 (el) 1977-03-30
JPS525793A (en) 1977-01-17
BE843402A (fr) 1976-12-27
GR60042B (en) 1978-04-01
IL49702A (en) 1979-01-31
SE421698B (sv) 1982-01-25
SE7607201L (sv) 1976-12-28
SU628820A3 (ru) 1978-10-15
YU146276A (en) 1982-05-31
IE43915B1 (en) 1981-07-01
ZA763270B (en) 1977-05-25
AT347950B (de) 1979-01-25
IL49702A0 (en) 1976-08-31
AU1537576A (en) 1978-01-05
FR2315274A1 (fr) 1977-01-21
MX3565E (es) 1981-03-13
CH596169A5 (el) 1978-02-28
LU75230A1 (el) 1977-02-18
NL183032C (nl) 1988-07-01
JPS607633B2 (ja) 1985-02-26
DE2628045A1 (de) 1977-01-20

Similar Documents

Publication Publication Date Title
YU39480B (en) Process for obtaining 4,5,6,7-tetrahydrotheno(2,3-c)pyridine derivatives
YU179482A (en) Process for obtaining new 1,4-dihydro-pyridine derivatives
HU173571B (hu) Sposob poluchenija novykh proizvodnykh 6,7-benzomorfana
YU237276A (en) Process for obtaining 2-amino-4-pyrimidone derivatives
HU177817B (en) Process for producing 3,4-dihydroquinasoline derivatives
YU39967B (en) Process for obtaining new pyridine derivatives
HU174707B (hu) Sposob poluchenija proizvodnykh 4,5-diaril-imidazola
YU39612B (en) Process for obtaining tetrahydro-4,5,6,7-thieno(3,2-c)pyridine
HU172460B (hu) Sposob poluchenija novykh proizvodnykh 5,6-digidro-3h-pirimidin-4-ona
HU177770B (en) Process for producing 2,2-difluoro-prostaglandine derivatives
YU42576A (en) Process for obtaining thieno (3,2-c) pyridine and derivatives thereof
HU172063B (hu) Sposob poluchenija priozvodnykh n-skobka-5-tetrazolil-skobka zakryta-1-okso-6-alkoksi-1h-pirimido-skobka-1,2-a-skobka zakryta-kinolin-2-karboksamidov
YU4277A (en) Process for obtaining thieno(3,2-e)pyridine derivatives
YU45877A (en) Process for obtaining new ditiepino(1,4)(2,3-c)pyrrole derivatives
HU173573B (hu) Sposob poluchenija novykh proizvodnykh 1,8-naftridina
NL181432C (nl) Werkwijze ter bereiding van 4,5,6,7-tetrahydrothieno(3,2-c)pyridinederivaten.
YU307176A (en) Process for obtaining 4-amino-trans-decahydroquinoline derivatives
HU174753B (hu) Sposob poluchenija proizvodnykh geksagidro-1h-indeno/1,2-b/piridina
YU309376A (en) Process for obtaining acetamido-oxime derivatives
YU162882A (en) Process for obtaining new dithiepino-(1,4)(2,3-c)-pyrrole derivatives
HU173064B (hu) Sposob poluchenija proizvodnykh 1,4-digidro-piridina
YU163674A (en) Process for obtaining 7-substituted 3,3a,4,5,6,7-hexahydro-3-substituted -2h-pyrazolo(4,3-c)pyridines
HU173772B (hu) Sposob poluchenija proizvodnykh piridina
HU174651B (hu) Sposob poluchenija proizvodnykh 2,3,4,5,6-pentanor-prostaglandinov
HU173195B (hu) Sposob poluchenija proizvodnykh 1,4-digidro-piridina